CFAR Adelante researcher investigates impact of HIV on cardiovascular health

CFAR-Adelante scholar Dr. Claudia Martinez’s research on the impact of HIV on cardiovascular health has been featured on South Florida’s Channel 10 news.

Cohort II CFAR Adelante Scholar, Claudia Martinez Wins NIDA Avenir Award to Study Cannabis and Heart Health in People with HIV

Claudia Martinez
Photos: University of Miami

Cohort II CFAR Adelante Scholar, Claudia Martinez (University of Miami) has been awarded the prestigious Avenir Award from the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health. The Avenir Award, which recognizes unique approaches to medical research and aims to create new avenues of investigation, will support her research study on the effects of cannabis use on cardiovascular health among people living with HIV. Learn more about Dr. Martinez’s project in this University of Miami press release.

Cohort IV CFAR Adelante Scholar, Nicholas Metheny His Mentee were Featured by the UM News for their Work to Address COVID-19 Concerns in the Sexual and Gender Minority Community

Nicholas Metheny and Maria Jose Baeza Robba
Photo: University of Miami/News@TheU

Cohort IV CFAR Adelante Scholar, Nicholas Metheny (University of Miami) and His Mentee were Featured by the UM News for their Work to Address COVID-19 Concerns in the Sexual and Gender Minority Community.

Cohort III CFAR Adelante Scholar, Valeria Cantos selected for the HIV Vaccine Trials Network’s inaugural Scientific Leadership Development program

Valeria Cantos Lucio

Cohort III CFAR Adelante Scholar, Valeria Cantos (Emory University) has been selected for the HIV Vaccine Trials Network’s inaugural Scientific Leadership Development program.

Dr. Cantos is an infectious disease specialist and since 2017 she has been a clinician and co-investigator at the Emory University Ponce de Leon clinical research site in Atlanta, Georgia. She has served as co-investigator for several HVTN studies, including HVTN 137, HVTN 706 (MOSAICO), and HVTN 704 (AMP study). She has also served as lead site investigator for several inpatient and outpatient COVID-19 studies, as well as scientist-led HIV prevention projects. Dr. Cantos is the lead investigator for the Community Engagement team at her site. She is invested in optimizing representation of Latinx and Black populations in HIV vaccine and prevention clinical trials.

Mentor: Colleen Kelley, M.D., M.P.H., Emory University School of Medicine